Knobil Katharine
SEC-identified person · CIK 1768011 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Korro Bio, Inc. KRRO | Director | filed 2024 - 2026 |
| Tapimmune INC. TPIV.OB | Director | filed 2021 - 2025 |
| Pliant Therapeutics, INC. PLRX | Director | filed 2022 - 2025 |
| Arena Pharmaceuticals INC ARNA | Director | filed 2020 - 2022 |
| Kaleido Biosciences, Inc. KLDO | See Remarks | filed 2019 - 2020 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.